We are pleased to announce that it received funding under the Applied Research and Development (ARAD) program. The funding approval is our first corporate sponsored research and testing agreement with Center for Biotechnology (CFB), L2P continues to build the momentum for the aggressive growth L2P is experiencing. Separately, this year, L2P closed research agreements for pre-clinical testing with several fast growing pharmaceutical companies based in greater New York area and is currently negotiating to acquire several other contracts. L2P research, headquartered in Stony Brook, NY, is a USA-based firm that provides integrated R&D support in all the key areas of Pharmaceutical development. We offer proprietary orthotopic and metastatic tumor models. Our services include, whole body animal imaging, small animal ultra sound MRI, CT scan and other advanced technologies. We provide a complete array of research services as required for Investigational New Drug Applications (IND). L2P Research at Stony Brook New York is fully committed to the judicious, humane use of animals in research and development. We operate in AAALAC accredited and GLP compliant audited facilities.
Direct: 844-205-9599 Fax: 631-444-8825
Corporate Headquarters 25 Health Sciences drive Stony brook, New York 11790 USA